| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |